Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis
By LabMedica International staff writers Posted on 14 Mar 2022 |
Leukocyte subsets are usually quantified with automated cell counting devices and particularly for stratification of lymphocyte subsets with flow cytometry. Despite broad application, conventional methods have several limitations.
DNA methylation (DNAm) is a covalent modification of cytosine residues, mostly at CG dinucleotides (CpG sites). By measuring the methylation level at CpG sites with cell-type–specific hypo- or hypermethylation, it is possible to quantify the composition of leukocyte subsets using statistical algorithms (deconvolution models).
Biomedical Engineers at the RWTH Aachen University (Aachen, Germany) and colleagues optimized and validated targeted DNAm assays for leukocyte deconvolution using 332 venous and 122 capillary blood samples from healthy donors. In addition, they tested 36 samples from ring trials and venous blood from 266 patients diagnosed with different hematological diseases. Deconvolution of cell types was determined with various models using DNAm values obtained by pyrosequencing or digital droplet PCR (ddPCR).
DNA was isolated from 150 µL venous or 50 µL capillary blood and bisulfite-treated with the EZ DNA Methylation Kit (Zymo Research, Irvine, CA, USA). PCR amplicons were sequenced on a PyroMark Q96 ID (Qiagen, Hilden, Germany) and analyzed with Qiagen’s PyroMark Q96 CpG 1.0.9. Digital Droplet Polymerase Chain Reaction (ddPCR) was carried out with the QX200 Droplet Digital reader (Bio-Rad, Hercules, CA, USA). Absolute leukocyte quantification by pyrosequencing was also performed.
The investigators reported that relative leukocyte quantification correlated with conventional blood counts for granulocytes, lymphocytes, B cells, T cells (CD4 or CD8), natural killer cells, and monocytes with pyrosequencing and ddPCR measurements. In some patients, particularly with hematopoietic malignancies, they observed outliers in epigenetic leukocyte counts, which could be discerned if relative proportions of leukocyte subsets did not sum up to 100%. Furthermore, absolute quantification was obtained by spiking blood samples with a reference plasmid of known copy number. The results confirmed cell-type–specific hypomethylation in the genes WDR20, CD4, CD8A, WIPI2, SLC15A4, and CENPA, which was more pronounced compared to the Illumina BeadChip data or reverse nonnegative least square (NNLS) estimation.
The authors concluded that targeted DNAm analysis by pyrosequencing or ddPCR is a valid alternative to quantify leukocyte subsets, but some assays require further optimization. The study was published on February 14, 2022 in the journal Clinical Chemistry.
Related Links:
RWTH Aachen University
Zymo Research
Qiagen
Bio-Rad
Latest Hematology News
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
- First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
- POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
- First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
- Handheld White Blood Cell Tracker to Enable Rapid Testing For Infections
- Smart Palm-size Optofluidic Hematology Analyzer Enables POCT of Patients’ Blood Cells
- Automated Hematology Platform Offers High Throughput Analytical Performance
- New Tool Analyzes Blood Platelets Faster, Easily and Accurately
- First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC
- Bleeding Risk Diagnostic Test to Reduce Preventable Complications in Hospitals
- True POC Hematology Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Blood Test Could Predict Outcomes in Emergency Department and Hospital Admissions
- Novel Technology Diagnoses Immunothrombosis Using Breath Gas Analysis
- Advanced Hematology System Allows Labs to Process Up To 119 Complete Blood Count Results per Hour
- Unique AI-Based Approach Automates Clinical Analysis of Blood Data